These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [Role of chelate-forming compounds in disorders of the incretory function of the pancreas]. Lazaris IaA; Veksler RI Vopr Med Khim; 1967; 13(3):256-60. PubMed ID: 4876365 [No Abstract] [Full Text] [Related]
4. [Pathogenesis of experimental diabetes produced by 8-(n-toluolsulfonylamino) quinoline]. Lazaris IaA; Krasavin IA; Dziomko VM; Bavel'skiĭ ZE Patol Fiziol Eksp Ter; 1971; 15(5):39-43. PubMed ID: 5152324 [No Abstract] [Full Text] [Related]
5. [Experimental diabetes caused by 5-(n-acetaminophenylazo-8-oxyquinoline and its prevention]. Lazaris AIa; Bavel'skiĭ ZE Patol Fiziol Eksp Ter; 1970; 14(2):44-8. PubMed ID: 5474018 [No Abstract] [Full Text] [Related]
6. [Prevention of dithizone diabetes with compounds containing sulfhydryl groups]. Lazaris IaA; Bavel'skiĭ ZE Biull Eksp Biol Med; 1969 Mar; 67(3):40-2. PubMed ID: 5821455 [No Abstract] [Full Text] [Related]
7. [Some regularities in the distribution of zinc, insulin and acid phosphatase in the islands of Langerhans of rabbits during the development of diabetes produced by selective injury of B cells]. Toroptsev IV; Eshchenko VA Arkh Patol; 1971; 33(3):43-9. PubMed ID: 4945986 [No Abstract] [Full Text] [Related]
11. [Attempts at induction of a diabetic condition in guinea pigs by different 8-hydroxy-quinolines]. Fiedler H Pharmazie; 1969 Jun; 24(6):338-40. PubMed ID: 5807397 [No Abstract] [Full Text] [Related]
12. [Mechanism of the harmful action of chelating agents on pancreatic islet cells]. Toroptsev IV; Eshchenko VA Biull Eksp Biol Med; 1982 Jul; 94(7):100-2. PubMed ID: 6751427 [TBL] [Abstract][Full Text] [Related]
14. [Histochemical reactions for zinc in the islands of Langerhans and diabetogenic effect of reagents used for this purpose]. Krasavin IA; Bavel'skiĭ ZE; Lazaris IaA; Dziomko VM Probl Endokrinol (Mosk); 1969; 15(3):102-6. PubMed ID: 4185099 [No Abstract] [Full Text] [Related]
15. [Experimental test with a copper chelating agent (sodium diethyldithiocarbamate) in relation to pathogenetic problems of metachromatic leukodystrophy and swayback]. De Biase G; Colafrancesch M; Borri P; Cardona G Arch De Vecchi Anat Patol; 1966 Jun; 47(2):297-323. PubMed ID: 6012315 [No Abstract] [Full Text] [Related]
16. [Modelling of diabetes mellitus using chelating agents]. Gol'dberg ED; Eshchenko VA Patol Fiziol Eksp Ter; 1989; (3):81-3. PubMed ID: 2677932 [No Abstract] [Full Text] [Related]
17. Proceedings: Antidotal effects of dithiocarb in experimental liver injury. Siegers CP; Strubelt O Naunyn Schmiedebergs Arch Pharmacol; 1975; 287 Suppl():R103. PubMed ID: 1143371 [No Abstract] [Full Text] [Related]
18. Fate of cobalt-60 I-nitroso 2-naphthol chelate in albino rats after intravenous administration. Jagadeesan V; Sivaramakrishnan VM Indian J Exp Biol; 1969 Oct; 7(4):217-20. PubMed ID: 5359087 [No Abstract] [Full Text] [Related]
19. Clioquinol attenuates zinc-dependent beta-cell death and the onset of insulitis and hyperglycemia associated with experimental type I diabetes in mice. Priel T; Aricha-Tamir B; Sekler I Eur J Pharmacol; 2007 Jun; 565(1-3):232-9. PubMed ID: 17434477 [TBL] [Abstract][Full Text] [Related]
20. [Behavior of radiozinc chelates in the mammal organism]. Catsch A; Du Khuong Le Strahlentherapie; 1966 Aug; 130(4):557-66. PubMed ID: 5996855 [No Abstract] [Full Text] [Related] [Next] [New Search]